What Have Been the Public Health Impacts of Cannabis Legalisation in the USA? A Review of Evidence on Adverse and Beneficial Effects
Purpose of Review
To summarise empirical research on the adverse and beneficial public health impacts of cannabis legalisation in states in the USA.
The most consistent finding from surveys of drug use is that the legalisation of medical cannabis has so far not had an effect on rates of use or cannabis use disorders among youth, but it has increased the frequency of use among adult cannabis users. There are conflicting findings on the impact of legalisation of medical and recreational cannabis use on the following: cannabis use disorders in adults, rates of motor vehicle accidents in which the driver was impaired by cannabis, rates of suicide, and opioid-related harms. The legalisation of recreational cannabis use has increased emergency room attendances for cannabis-related medical conditions (acute adverse psychological effects, hyperemesis, and accidental poisoning of children). There is no evidence to date on the impact of medical or recreational legalisation on the prevalence of mental disorders such as psychoses, depression, and anxiety.
There is suggestive evidence that cannabis legalisation is associated with a range of public health consequences. However, current evidence is limited in the capacity to confidently conclude that these changes are the result of cannabis legalisation. The impacts on public health may take some years to become apparent.
KeywordsCannabis Marijuana Legalisation Public health Medical marijuana laws Legislation
CYSAR is supported by Commonwealth funding from the Australian Government provided under the Drug and Alcohol Program. JL is supported by the University of Queensland development fellowship. We thank Research librarian Sarah Yeates for assisting with literature searching, bibliography management, and proof-editing for this review.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 5.Sabet KA. The (often unheard) case against marijuana leniency. In: Earleywine M, editor. Pot politics: marijuana and the costs of prohibition. Oxford: Oxford University Press; 2007. p. 325–52.Google Scholar
- 8.NASEM. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: National Academies Press for the National Academies of Sciences Engineering and Medicine; 2017.Google Scholar
- 9.•• Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse. 2019;1–21. This study provides a comprehensive review of the impact of cannabis legalization on cannabis use and use disorders.Google Scholar
- 11.Anderson DM, Hansen B, Rees DI, Sabia JJ. Association of marijuana laws with teen marijuana use: new estimates from the Youth Risk Behavior Surveys. JAMA Pediatr. 2019.Google Scholar
- 12.•• Melchior M, Nakamura A, Bolze C, Hausfater F, El Khoury F, Mary-Krause M, et al. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis. BMJ Open. 2019;9:e025880. This study provides a systematic review and meta-analysis of the impact of cannabis policies on cannabis use in adolescents and young people. PubMedPubMedCentralCrossRefGoogle Scholar
- 13.Hall W, Renström M, Poznyak V. The health and social effects of nonmedical cannabis use. Geneva: World Health Organization; 2016.Google Scholar
- 24.Lane TJ, Hall W. Traffic fatalities within US states that have legalized recreational cannabis sales and their neighbours. Addiction. 2019.Google Scholar
- 26.• Wang GS, Hall K, Vigil D, Banerji S, Monte A, VanDyke M. Marijuana and acute health care contacts in Colorado. Prev Med. 2017;104:24–30. This study reported on changes in the impact of cannabis on hospitalizations, emergency department (ED) visits, and regional poison center (RPC) calls in Colorado across 2000–2015. PubMedPubMedCentralCrossRefGoogle Scholar
- 36.Patel RS, Katta SR, Patel R, Ravat V, Gudipalli R, Patel V, et al. Cannabis use disorder in young adults with acute myocardial infarction: trend inpatient study from 2010 to 2014 in the United States. Cureus. 2018;10.Google Scholar
- 38.• Richards JR, Smith NE, Moulin AK. Unintentional cannabis ingestion in children: a systematic review. J Pediatr. 2017;190:142–52. This study presented reports of unintentional cannabis ingestions in children in states that have decriminalized medical and recreational cannabis. PubMedCrossRefPubMedCentralGoogle Scholar
- 39.Koski L. Retail marijuana product manufacturing, packaging, and labeling compliance guidance. In: Marijuana Enforcement Division DoR (ed). Lakewood, CO, USA; 2017.Google Scholar
- 48.•• Grucza RA, Hur M, Agrawal A, Krauss MJ, Plunk AD, Cavazos-Rehg PA, et al. A reexamination of medical marijuana policies in relation to suicide risk. Drug Alcohol Depend. 2015;152:68–72. This study used cause of death data from National Vital Statistics System to re-examine the impact of cannabis policies on suicide risks adjusting for ethnic/race, tobacco policies, and state-level characteristics across 1990–2010. PubMedPubMedCentralCrossRefGoogle Scholar
- 53.• Subbaraman MS. Substitution and complementarity of alcohol and cannabis: a review of the literature. Subst Use Misuse. 2016;51:1399–414 This review summarizes evidence on alcohol and cannabis use as substitution or complementation in the context of cannabis legalization in the USA across different sociodemographic populations. PubMedPubMedCentralCrossRefGoogle Scholar
- 54.• Cerda M, Sarvet AL, Wall M, Feng T, Keyes KM, Galea S, et al. Medical marijuana laws and adolescent use of marijuana and other substances: alcohol, cigarettes, prescription drugs, and other illicit drugs. Drug Alcohol Depend. 2018;183:62–8. This study presents evidence across 1991–2015 on the relationship between state MML and use of cannabis, cigarettes, illicit drugs, nonmedical use of prescription opioids, amphetamines, and tranquilizers, as well as binge drinking in adolescents. PubMedCrossRefGoogle Scholar
- 56.Veligati S, Howdeshell S, Beeler-Stinn S, Lingam D, Allen P, Chen L-S et al. Changes in alcohol and tobacco consumption in response to medical and recreational cannabis legalization: evidence from US state tax receipt data. 2019. Available at: https://ssrn.com/abstract=3337354. Accesed 20 Feb 2019
- 62.•• Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci USA. 2019;116:12624–6. This study provides strong evidence on the inconsistent association between state medical cannabis laws and opioid overdose mortality by extending previous analyses of 1999–2010 data to analysis of data through to 2017. CrossRefGoogle Scholar
- 69.Hammond D, Goodman S, Leos-Toro C, Wadsworth E, Reid JL, Hall W, et al. International Cannabis Policy Study. University of Waterloo. 2019. http://davidhammond.ca/projects/drugs-policy/illicit-drug-use-among-youth/. Accessed 8 Aug 2019.